WO2001093762A3 - A fail-sure computer aided method for anticoagulant treatment - Google Patents

A fail-sure computer aided method for anticoagulant treatment Download PDF

Info

Publication number
WO2001093762A3
WO2001093762A3 PCT/DK2001/000397 DK0100397W WO0193762A3 WO 2001093762 A3 WO2001093762 A3 WO 2001093762A3 DK 0100397 W DK0100397 W DK 0100397W WO 0193762 A3 WO0193762 A3 WO 0193762A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug
take
time
computer system
corresponding dose
Prior art date
Application number
PCT/DK2001/000397
Other languages
French (fr)
Other versions
WO2001093762A9 (en
WO2001093762A2 (en
Inventor
Peter Michael Nielsen
Original Assignee
Medimage Aps
Peter Michael Nielsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimage Aps, Peter Michael Nielsen filed Critical Medimage Aps
Priority to AU63785/01A priority Critical patent/AU6378501A/en
Publication of WO2001093762A2 publication Critical patent/WO2001093762A2/en
Publication of WO2001093762A3 publication Critical patent/WO2001093762A3/en
Publication of WO2001093762A9 publication Critical patent/WO2001093762A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150389—Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150748—Having means for aiding positioning of the piercing device at a location where the body is to be pierced
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150847—Communication to or from blood sampling device
    • A61B5/150854—Communication to or from blood sampling device long distance, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101—Details
    • A61B5/15103—Piercing procedure
    • A61B5/15107—Piercing being assisted by a triggering mechanism
    • A61B5/15113—Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • A61B5/15188—Constructional features of reusable driving devices
    • A61B5/1519—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for propelling the piercing unit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor

Abstract

The present invention relates to a method for determining a set of corresponding dose of a drug and time to take the drug. The method comprises the step of measuring a blood coagulation value at a patient and by use a first computer system determining the set of corresponding dose and time to take the drug. The determination by use of the computer system is also preferably performed at the patient. Furthermore, the present invention relates to a validation method in which data relating to the determination of the set of corresponding dose and time to take the drug is transmitted to a second computer system. By use of this second computer system a set of corresponding dose and time to take the drug is determined and this set may be validated against the set determined by the first computer system. The present invention also relates to a personal apparatus at the patient having means for taking a blood sample, means adapted to determine a set of corresponding dose and time to take the drug and means for transceiving data to and from a validation apparatus. The validation apparatus comprises means for transceiving data to and from the personal apparatus, means adapted to determining a set of corresponding dose and time to take the dose based on data received from the personal apparatus and means adapted to validate this set to the set determined by the personal apparatus.
PCT/DK2001/000397 2000-06-09 2001-06-08 A fail-sure computer aided method for anticoagulant treatment WO2001093762A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU63785/01A AU6378501A (en) 2000-06-09 2001-06-08 A fail-sure computer aided method for anticoagulant treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000896 2000-06-09
DKPA200000896 2000-06-09

Publications (3)

Publication Number Publication Date
WO2001093762A2 WO2001093762A2 (en) 2001-12-13
WO2001093762A3 true WO2001093762A3 (en) 2002-03-07
WO2001093762A9 WO2001093762A9 (en) 2002-03-28

Family

ID=8159549

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2001/000397 WO2001093762A2 (en) 2000-06-09 2001-06-08 A fail-sure computer aided method for anticoagulant treatment

Country Status (2)

Country Link
AU (1) AU6378501A (en)
WO (1) WO2001093762A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232461B2 (en) 2003-10-29 2007-06-19 Cordis Neurovascular, Inc. Neck covering device for an aneurysm
ES2603087T3 (en) 2006-06-01 2017-02-23 F. Hoffmann-La Roche Ag A system and method to manage information related to requests for test samples in a laboratory environment
EP1862928A1 (en) * 2006-06-01 2007-12-05 F.Hoffmann-La Roche Ag A system and a method for managing sample test results and respective sample result context information
EP2538360A1 (en) 2011-06-16 2012-12-26 Koninklijke Philips Electronics N.V. Method of predicting a blood dilution risk value
ES2942668T3 (en) * 2017-03-23 2023-06-05 Bayer Ag Support for patients with repeated medication intake
AU2018297208B2 (en) * 2017-07-06 2023-11-09 Becton, Dickinson And Company Biological fluid collection device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544651A (en) * 1992-09-08 1996-08-13 Wilk; Peter J. Medical system and associated method for automatic treatment
WO1997029447A2 (en) * 1996-02-09 1997-08-14 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
WO2000032101A1 (en) * 1998-12-02 2000-06-08 Sulzer Carbomedics Inc. Method and apparatus for monitoring anticoagulation levels

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544651A (en) * 1992-09-08 1996-08-13 Wilk; Peter J. Medical system and associated method for automatic treatment
WO1997029447A2 (en) * 1996-02-09 1997-08-14 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
WO2000032101A1 (en) * 1998-12-02 2000-06-08 Sulzer Carbomedics Inc. Method and apparatus for monitoring anticoagulation levels

Also Published As

Publication number Publication date
WO2001093762A9 (en) 2002-03-28
AU6378501A (en) 2001-12-17
WO2001093762A2 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
WO2006056907A3 (en) Depression detection system
WO2003030731A3 (en) Method and apparatus for improving clinical accuracy of analyte measurements
WO2007014147A3 (en) Method and system for monitoring medical treatment
ATE401038T1 (en) AUTOMATIC LUNG PARAMETERS ESTIMATION
Lim et al. Predicting the risk of incident hypertension in a Korean middle‐aged population: Korean genome and epidemiology study
GB2413078B (en) A system or method for assessing a subject's pedal blood circulation
WO2004057300A3 (en) Determining a minimum effective dose of an inhaled drug for an individual at a given time
WO2003097121A3 (en) 'biosensor for dialysis therapy'
ATE440540T1 (en) APPARATUS AND METHOD FOR USING CURVAGE-BASED FEATURES FOR HEARTBEAT DETERMINATION
SE0200624D0 (en) Medical device
EP1217379A3 (en) Method for determining the ion concentration of blood and dialysis apparatus
EP1645227A3 (en) Device and method for segmental bioimpedance measurements of a dialysis patient
WO2003087775A3 (en) Monitoring blood substances using self-sampled tears
PL1763316T3 (en) A method and a device for determining the hydration and/or nutrition status of a patient
WO2002012981A3 (en) Method and system for a distributed analytical and diagnostic software over the intranet and internet environment
WO2003107252A3 (en) Method and system for monitoring patient care
WO2002079776A3 (en) Method and apparatus for calculating blood flow parameters
NZ311397A (en) System for measuring blood oxygen levels
MXPA04002038A (en) Non-invasive device and method for the diagnosis of pulmonary vascular occlusions.
WO2003082096A8 (en) System and method for managing a patient treatment program
WO2001093762A3 (en) A fail-sure computer aided method for anticoagulant treatment
WO2004031414A3 (en) Method for diagnosing prostate cancer
WO2002095358A3 (en) System and method for monitoring or treating a health condition
EP1136570A3 (en) Carrier for gene detection and it's use for detecting validity of interferon therapy
WO2000031531A8 (en) Monitoring patient compliance and bioavailability of drugs by deproteinizing body fluids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 15 AND 19, DESCRIPTION, REPLACED BY NEW PAGES 15 AND 19; PAGES 1/2-2/2, DRAWINGS, REPLACED BYNEW PAGES 1/2-2/2; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP